These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2664736)

  • 1. Intermediate filament expression and the progression of prostatic cancer as studied in the Dunning R-3327 rat prostatic carcinoma system.
    Ramaekers FC; Verhagen AP; Isaacs JT; Feitz WF; Moesker O; Schaart G; Schalken JA; Vooijs GP
    Prostate; 1989; 14(4):323-39. PubMed ID: 2664736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Murine monoclonal antibodies reactive with a variety of androgen independent Dunning rat prostate adenocarcinoma sublines also reactive with human prostate adenocarcinoma.
    Tjota A; Lee MT; Isaacs JT; Kadohama N; Lee CL
    J Urol; 1991 Jul; 146(1):205-12. PubMed ID: 2056591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in expression of oligosaccharide determinants by phenotypically distinct sublines of the Dunning 3327 rat prostate cancer.
    Abel PD; Foster CS; Tebbutt S; Williams G
    J Urol; 1990 Sep; 144(3):760-5. PubMed ID: 2388349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship of androgen receptor levels to androgen responsiveness in the Dunning R3327 rat prostate tumor sublines.
    Diamond DA; Barrack ER
    J Urol; 1984 Oct; 132(4):821-7. PubMed ID: 6471235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential oxygen dynamics in two diverse Dunning prostate R3327 rat tumor sublines (MAT-Lu and HI) with respect to growth and respiratory challenge.
    Zhao D; Constantinescu A; Hahn EW; Mason RP
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):744-56. PubMed ID: 12062621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased expression of E-cadherin in the progression of rat prostatic cancer.
    Bussemakers MJ; van Moorselaar RJ; Giroldi LA; Ichikawa T; Isaacs JT; Takeichi M; Debruyne FM; Schalken JA
    Cancer Res; 1992 May; 52(10):2916-22. PubMed ID: 1581909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunobiology of the Dunning R-3327 rat prostate adenocarcinoma sublines: plasma and tumor effusion prostaglandins.
    Shaw MW; Ablin RJ; Ray P; Rubenstein M; Guinan PD; McKiel CF
    Am J Reprod Immunol Microbiol; 1985 Jul; 8(3):77-9. PubMed ID: 3861106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and localization of androgen receptor in the R-3327 Dunning rat prostatic adenocarcinoma.
    Quarmby VE; Beckman WC; Cooke DB; Lubahn DB; Joseph DR; Wilson EM; French FS
    Cancer Res; 1990 Feb; 50(3):735-9. PubMed ID: 2404576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metastatic potential and substrate dependence of cell motility and attachment in the Dunning R-3327 rat prostatic adenocarcinoma model.
    Mohler JL; Levy F; Sharief Y
    Cancer Res; 1991 Dec; 51(24):6580-5. PubMed ID: 1742730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of ras proto-oncogenes in the Dunning R3327 rat prostatic adenocarcinoma system.
    Cooke DB; Quarmby VE; Petrusz P; Mickey DD; Der CJ; Isaacs JT; French FS
    Prostate; 1988; 13(4):273-87. PubMed ID: 3064050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of metastatic potential by cancer cell motility in the Dunning R-3327 prostatic adenocarcinoma in vivo model.
    Doyle GM; Sharief Y; Mohler JL
    J Urol; 1992 Feb; 147(2):514-8. PubMed ID: 1732634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intermediate filament and cross-linked envelope expression in human lung tumor cell lines.
    Banks-Schlegel SP; Gazdar AF; Harris CC
    Cancer Res; 1985 Mar; 45(3):1187-97. PubMed ID: 2578876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoregulatory markers in rats carrying Dunning R3327 H, G, or MAT-LyLu prostatic adenocarcinoma variants.
    Rubenstein M; Shaw MW; McKiel CF; Ray PS; Guinan PD
    Cancer Res; 1987 Jan; 47(1):178-82. PubMed ID: 3491674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro characterization of MAT LyLu: a Dunning rat prostate adenocarcinoma tumor subline.
    Wenger AS; Mickey DD; Hall M; Silverman LM; Mickey GH; Fried FA
    J Urol; 1984 Jun; 131(6):1232-6. PubMed ID: 6539387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Keratin immunoreactivity in the benign and neoplastic human prostate.
    Brawer MK; Peehl DM; Stamey TA; Bostwick DG
    Cancer Res; 1985 Aug; 45(8):3663-7. PubMed ID: 2410099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of prolactin on rat dorsolateral prostate and R3327 prostatic tumor sublines.
    Johnson MP; Thompson SA; Lubaroff DM
    J Urol; 1985 Jun; 133(6):1112-20. PubMed ID: 4039764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical detection of intermediate filament proteins in formalin fixed normal and neoplastic canine tissues.
    Desnoyers MM; Haines DM; Searcy GP
    Can J Vet Res; 1990 Jun; 54(3):360-5. PubMed ID: 1696160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical distribution pattern of intermediate filament proteins in 50 feline neoplasms.
    Martín de las Mulas J; Espinosa de los Monteros A; Carrasco L; van Niel M; Fernández A
    Vet Pathol; 1995 Nov; 32(6):692-701. PubMed ID: 8592805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of epithelial- and neural type of intermediate filament proteins in human lung tumors.
    Ramaekers F; Broers J; Rot MK; Oostendorp T; Wagenaar S; Vooijs P
    Acta Histochem Suppl; 1987; 34():45-56. PubMed ID: 3033739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential sensitivity of three sublines of the rat Dunning prostate tumor system R3327 to radiation and/or local tumor hyperthermia.
    Peschke P; Hahn EW; Wenz F; Lohr F; Braunschweig F; Wolber G; Zuna I; Wannenmacher M
    Radiat Res; 1998 Oct; 150(4):423-30. PubMed ID: 9768856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.